Cargando…
A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
Ornithine transcarbamylase deficiency (OTCD, OMIM# 311250) is an inherited X-linked urea cycle disorder that is characterized by hyperammonemia and orotic aciduria. In this report, we describe a new animal model of OTCD caused by a spontaneous mutation in the mouse Otc gene (c.240T>A, p.K80N). Th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315515/ https://www.ncbi.nlm.nih.gov/pubmed/25647322 http://dx.doi.org/10.1371/journal.pone.0116594 |
_version_ | 1782355486024138752 |
---|---|
author | Tarasenko, Tatyana N. Rosas, Odrick R. Singh, Larry N. Kristaponis, Kara Vernon, Hilary McGuire, Peter J. |
author_facet | Tarasenko, Tatyana N. Rosas, Odrick R. Singh, Larry N. Kristaponis, Kara Vernon, Hilary McGuire, Peter J. |
author_sort | Tarasenko, Tatyana N. |
collection | PubMed |
description | Ornithine transcarbamylase deficiency (OTCD, OMIM# 311250) is an inherited X-linked urea cycle disorder that is characterized by hyperammonemia and orotic aciduria. In this report, we describe a new animal model of OTCD caused by a spontaneous mutation in the mouse Otc gene (c.240T>A, p.K80N). This transversion in exon 3 of ornithine transcarbamylase leads to normal levels of mRNA with low levels of mature protein and is homologous to a mutation that has also been described in a single patient affected with late-onset OTCD. With higher residual enzyme activity, spf-J were found to have normal plasma ammonia and orotate. Baseline plasma amino acid profiles were consistent with mild OTCD: elevated glutamine, and lower citrulline and arginine. In contrast to WT, spf-J displayed baseline elevations in cerebral amino acids with depletion following immune challenge with polyinosinic:polycytidylic acid. Our results indicate that the mild spf-J mutation constitutes a new mouse model that is suitable for mechanistic studies of mild OTCD and the exploration of cerebral pathophysiology during acute decompensation that characterizes proximal urea cycle dysfunction in humans. |
format | Online Article Text |
id | pubmed-4315515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43155152015-02-13 A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation Tarasenko, Tatyana N. Rosas, Odrick R. Singh, Larry N. Kristaponis, Kara Vernon, Hilary McGuire, Peter J. PLoS One Research Article Ornithine transcarbamylase deficiency (OTCD, OMIM# 311250) is an inherited X-linked urea cycle disorder that is characterized by hyperammonemia and orotic aciduria. In this report, we describe a new animal model of OTCD caused by a spontaneous mutation in the mouse Otc gene (c.240T>A, p.K80N). This transversion in exon 3 of ornithine transcarbamylase leads to normal levels of mRNA with low levels of mature protein and is homologous to a mutation that has also been described in a single patient affected with late-onset OTCD. With higher residual enzyme activity, spf-J were found to have normal plasma ammonia and orotate. Baseline plasma amino acid profiles were consistent with mild OTCD: elevated glutamine, and lower citrulline and arginine. In contrast to WT, spf-J displayed baseline elevations in cerebral amino acids with depletion following immune challenge with polyinosinic:polycytidylic acid. Our results indicate that the mild spf-J mutation constitutes a new mouse model that is suitable for mechanistic studies of mild OTCD and the exploration of cerebral pathophysiology during acute decompensation that characterizes proximal urea cycle dysfunction in humans. Public Library of Science 2015-02-03 /pmc/articles/PMC4315515/ /pubmed/25647322 http://dx.doi.org/10.1371/journal.pone.0116594 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Tarasenko, Tatyana N. Rosas, Odrick R. Singh, Larry N. Kristaponis, Kara Vernon, Hilary McGuire, Peter J. A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation |
title | A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation |
title_full | A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation |
title_fullStr | A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation |
title_full_unstemmed | A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation |
title_short | A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation |
title_sort | new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315515/ https://www.ncbi.nlm.nih.gov/pubmed/25647322 http://dx.doi.org/10.1371/journal.pone.0116594 |
work_keys_str_mv | AT tarasenkotatyanan anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT rosasodrickr anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT singhlarryn anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT kristaponiskara anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT vernonhilary anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT mcguirepeterj anewmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT tarasenkotatyanan newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT rosasodrickr newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT singhlarryn newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT kristaponiskara newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT vernonhilary newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation AT mcguirepeterj newmousemodelofmildornithinetranscarbamylasedeficiencyspfjdisplayscerebralaminoacidperturbationsatbaselineanduponsystemicimmuneactivation |